111 to Announce Third Quarter 2020 Unaudited Financial Results on November 19, 2020
SHANGHAI, Oct. 22, 2020 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading digital healthcare platform committed to digitally connecting patients with healthcare products and services inChina, today announced that it will report its unaudited financial results for the thir...
111, Inc. Teams Up with Bayer Healthcare to Explore the Vast Blue Ocean of Online Healthcare
SHANGHAI, Oct. 19, 2020 /PRNewswire/ -- On September 24, 111, Inc. (the "Company" or "111") entered into a strategic partnership (the "Partnership") withBayer Healthcare Co. Ltd. ("Bayer Healthcare"). The two companies will collaborate on drug commercialization initiatives inChina, including the ...
111, Inc. Teams Up with Huluwa Pharmaceutical to Explore the New Domain of "Internet + pharmaceutical"
SHANGHAI, Oct. 15, 2020 /PRNewswire/ -- On September 24, 111, Inc. (NASDAQ: YI) (the "Company" or "111") and Hainan Huluwa Pharmaceutical Group Co., Ltd. (SH: 605199) ("Huluwa Pharmaceutical") signed a strategic partnership agreement in Shanghai. Mrs. LIU Jingping, Chairperson of Huluwa Pharmace...
111 to be the Omni-channel Drug Commercialization Partner of Xiangxu Pharmaceutical for Traditional Chinese Medicine
SHANGHAI, Oct. 15, 2020 /PRNewswire/ -- On September 24, 111, Inc. (the "Company" or "111") and Guangzhou Xiangxue Pharmaceutical Co., Ltd. ("Xiangxue Pharmaceutical") officially signed a strategic partnership agreement (the "Agreement") to deepen collaboration to further develop the "Internet + ...
111, Inc. and Shanghai Uniondrug Information Technology Join Hands to Advance Innovation in Commercial Insurance Payment
SHANGHAI, Oct. 15, 2020 /PRNewswire/ -- On September 24, 111, Inc. (NASDAQ: YI) ("111") and Shanghai Uniondrug Information Technology Co., Ltd ("Shanghai Uniondrug") officially signed a strategic partnership agreement (the "Agreement"). The two companies will share resources and leverage each co...
111, Inc. Builds Digitally-enabled, Omni-channel Drug Commercialization Platform as Part of its Goal to Provide Full Life-cycle Healthcare Management Solutions for Patients
SHANGHAI, Sept. 30, 2020 /PRNewswire/ -- On September 24, 2020, 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading digital healthcare platform dedicating to digitally connecting patients with drugs and healthcare services inChina, hosted its 3rd annual China Online Healthcare Summit and P...
111, Inc. Partners with Baiyunshan Pharmaceutical Sales in Digital Medicine Innovation
SHANGHAI, Sept. 4, 2020 /PRNewswire/ -- On August 25, 111, Inc. ("111" or the "Company") (Nasdaq: YI), a company dedicated to digitally connecting patients with drugs and healthcare services inChina, and Guangzhou Baiyunshan Pharmaceutical Sales Co., Ltd. ("Baiyunshan Pharmaceutical Sales"), an ...
111, Inc. Announces Second Quarter 2020 Unaudited Financial Results
SHANGHAI, Aug. 20, 2020 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a company dedicated to digitally connecting patients with drugs and healthcare services inChina, today announced its unaudited financial results for the second quarter endedJune 30, 2020. Second Quarter 2020...
111, Inc. Announces New Capital Injection and Strategic Plan to Expand Access to China's Capital Markets
* Completion of new capital injection in principal subsidiary Yao Fang Shanghai * Initiation to list shares of principal subsidiary Yao Fang Shanghai on the STAR Market * 111 firmly committed to maintaining Nasdaq listing status SHANGHAI, Aug. 20, 2020 /PRNewswire/ -- 111, Inc. ("111" or th...
111 to Announce Second Quarter 2020 Unaudited Financial Results on August 20, 2020
SHANGHAI, July 31, 2020 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a Company dedicated to digitally connecting patients with drugs and healthcare services inChina, today announced that it will report its unaudited financial results for the second quarter endedJune 30, 2020, ...
111, Inc. Launched Lung Cancer Patient Care Program "Cloud Enabled Lung Cancer Care by Great Doctors" for Full Life-cycle Management of Tumor
SHANGHAI, July 27, 2020 /PRNewswire/ -- Aiming to provide better health management services to lung cancer patients, "Cloud Enabled Lung Cancer Care by Great Doctors" was officially launched inShanghai on July 25, 2020. The lung cancer patient care program (the "Program"), spearheaded by China...
111, Inc. Announces First Quarter 2020 Unaudited Financial Results
SHANGHAI, May 21, 2020 /PRNewswire/ --111, Inc. ("111" or the "Company") (NASDAQ: YI), a Company dedicated to digitally connecting patients with drugs and healthcare services inChina, today announced its unaudited financial results for the first quarter endedMarch 31, 2020. First Quarter 2020 Hi...
111 to Launch First Online Diabetes Patient Management Platform with Lilly China
SHANGHAI, May 8, 2020 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (Nasdaq: YI), a leading integrated online and offline healthcare platform in China, today announced that it is launching a new diabetes patient management platform in cooperation withLilly China. The two companies will work...
111 to Announce First Quarter 2020 Unaudited Financial Results on May 21, 2020
SHANGHAI, May 7, 2020 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform inChina , today announced that it will report its unaudited financial results for the first quarter endedMarch 31, 2020, before the U.S. market opens o...
Mr. Anfeng Guo, a Former BMS Oncology Business Unit Vice President Joins 111, Inc. as Chief Innovation Officer
SHANGHAI, May 6, 2020 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (Nasdaq: YI), a leading integrated online and offline healthcare platform in China, today announced that Mr. Anfeng Guo ("Mr. Guo"), a former Vice President of Oncology Business Unit at Bristol Myers Squibb, is appointed as C...
111 Launched the Overseas Direct Delivery Service
SHANGHAI, May 4, 2020 /PRNewswire/ -- 111, Inc. (" 111" or the "Company") (NASDAQ: YI), a leading integrated online and offline healthcare platform in China, announced today that it has launched its Overseas Direct Delivery service (the "Service") addressing the critical global shortage of persona...
111 Files Annual Report on Form 20-F for Fiscal Year Ended 2019
SHANGHAI, April 17, 2020 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (Nasdaq: YI), a leading integrated online and offline healthcare platform in China, today announced it has filed its annual report on Form 20-F for the fiscal year endedDecember 31, 2019 with the United States Securities a...
111 and Wenjiang People's Hospital to Build Online Cancer Diagnosis and Treatment Platform
SHANGHAI, March 27, 2020 /PRNewswire/ -- China's leading online pharmaceutical network and healthcare service provider is partnering with the Wenjiang People's Hospital inChengdu to build an online cancer diagnosis and treatment platform for rare tumors using imported drugs. The new rare tumor pl...
111 Launches Free Consultation Services for Chinese Citizens Abroad against COVID-19
COVID-19 continues to spread across the world, especially in Europe. According to John Hopkins University's latest real-time statistics, as of10:00 a.m. Beijing Time onMarch 19, the COVID-19 had sickened more than 217,000 people globally, with 136,100 cases diagnosed outsideChina ( https://corona...
111, Inc. Announces Fourth Quarter and Fiscal Year 2019 Unaudited Financial Results
SHANGHAI, March 12, 2020 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading integrated online and offline healthcare platform in China, today announced its unaudited financial results for the fourth quarter and fiscal year endedDecember 31, 2019. Fourth Quarter 2019 Highl...
